The exercise period for warrants series TO 3 (the “Warrants”) that were issued in conjunction with Amniotics AB’s (“Amniotics” or the “Company”) rights issue of units which was announced on
Terms for the Warrants in brief:
The exercise price is
The exercise period runs from
Upon full exercise of all Warrants, a maximum of 2,502,044,100 shares may be added.
Upon full exercise of all Warrants, the Company will receive approximately MSEK 25 before issue costs.
Upon full exercise of all Warrants, the number of shares in
2,502,044,100 shares to 5,212,591,875 shares and the share capital will increase with
The announcement of the outcome is planned to:
In total,
In the event of full exercise of all Warrants, the Company will receive approximately MSEK 25 before issue costs. In order for the Warrants not to expire and lose their value, they must be actively sold by
In the event of full exercise of all Warrants for subscription of shares, the Company will raise approximately MSEK 25 before issue costs. Complete terms and conditions for the Warrants are available at Amniotics’ website www.amniotics.com.
Note that Warrants that have not been actively sold by
Exercise of Warrants
Trustee-registered Warrants
If the warrant holder holds Warrants in a deposit account, in an investment savings account or endowment insurance (trustee-registered holdings), subscription and payment will take place with the trustee, which will provide further instructions on how to exercise the Warrants. The warrant holder should contact their trustee well in advance for further instructions regarding exercising of the Warrants.
Directly registered Warrants (securities account)
Registration is done through a registration form available on the websites of
Advisors
IMPORTANT INFORMATION
The information in this press release does not contain or constitute an offer to acquire, subscribe for or otherwise trade in shares, warrants or other securities in
For more information please contact
CEO,
Phone: +46 (0) 763 0840 91
Email: ml@amniotics.com
About
The company is listed at Nasdaq First North Growth Market in
Learn more at www.amniotics.com.
Attachments
© Modular Finance, source